Compounds modulating function of telomeric proteins TRF1 and TRF2
2023/49/B/NZ7/03456
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ5_07: Leczenie chorób człowieka
- ST5_15: Chemia medyczna
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Politechnika Gdańska, Wydział Chemiczny
Voivodeship: pomorskie
Principal investigator (from the host institution)
prof. Maciej Wojciech Bagiński
Number of co-investigators in the project: 13
Call
OPUS 25 – announced on 2023-03-16
- Amount awarded
- 2 813 440 PLN
- Project start date
- 2024-01-29
- Project end date
- 2028-01-28
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Targeting shelterin proteins for cancer therapy
- Authors:
- Wioletta Brankiewicz-Kopcinska, Anoop Kallingal, Radoslaw Krzemieniecki, Maciej Baginski
- Academic press:
- Drug Discovery Today (year: 2024, volume: 29, pages: 104056), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.drudis.2024.104056 – link to the publication